Rehmann Capital Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.51M Buy
29,158
+857
+3% +$98.9K 0.18% 89
2025
Q4
$2.98M Sell
28,301
-2,059
-7% -$193K 0.16% 103
2025
Q3
$2.54M Sell
30,360
-2,844
-9% -$234K 0.14% 112
2025
Q2
$2.63M Buy
33,204
+409
+1% +$32.5K 0.16% 100
2025
Q1
$2.94M Sell
32,795
-164
-0.5% -$15.3K 0.19% 97
2024
Q4
$3.28M Buy
32,959
+102
+0.3% +$10.5K 0.21% 89
2024
Q3
$3.73M Buy
32,857
+2,707
+9% +$322K 0.24% 81
2024
Q2
$3.73M Buy
30,150
+3,551
+13% +$457K 0.27% 75
2024
Q1
$3.51M Sell
26,599
-195
-0.7% -$24K 0.26% 71
2023
Q4
$2.92M Sell
26,794
-59
-0.2% -$6.12K 0.24% 79
2023
Q3
$2.76M Sell
26,853
-357
-1% -$38.5K 0.26% 75
2023
Q2
$3.14M Sell
27,210
-122
-0.4% -$13.9K 0.28% 68
2023
Q1
$2.91M Sell
27,332
-443
-2% -$47.8K 0.27% 77
2022
Q4
$3.08M Buy
27,775
+576
+2% +$58.9K 0.32% 69
2022
Q3
$2.34M Sell
27,199
-1,001
-4% -$89.4K 0.26% 81
2022
Q2
$2.57M Buy
28,200
+1,276
+5% +$113K 0.28% 70
2022
Q1
$2.21M Buy
26,924
+1,477
+6% +$116K 0.21% 94
2021
Q4
$1.95M Sell
25,447
-266
-1% -$21.2K 0.18% 98
2021
Q3
$1.93M Sell
25,713
-205
-0.8% -$15.6K 0.18% 91
2021
Q2
$2.02M Sell
25,918
-2,640
-9% -$196K 0.19% 84
2021
Q1
$2.1M Buy
28,558
+1,503
+6% +$111K 0.21% 79
2020
Q4
$2.11M Sell
27,055
-69
-0.3% -$5.28K 0.24% 77
2020
Q3
$2.15M Buy
27,124
+698
+3% +$54.7K 0.27% 69
2020
Q2
$1.95M Sell
26,426
-516
-2% -$38.8K 0.27% 73
2020
Q1
$1.98M Buy
+26,942
New +$2.12M 0.32% 53
2019
Q3
$2.23M Sell
27,786
-635
-2% -$50.9K 0.27% 42
2019
Q2
$2.27M Buy
28,421
+2,640
+10% +$202K 0.28% 60
2019
Q1
$2.05M Buy
25,781
+54
+0.2% +$4.04K 0.28% 59
2018
Q4
$1.88M Buy
25,727
+7,137
+38% +$504K 0.28% 41
2018
Q3
$1.26M Sell
18,590
-1,661
-8% -$106K 0.17% 99
2018
Q2
$1.09M Buy
20,251
+3,813
+23% +$215K 0.16% 113
2018
Q1
$854K Sell
16,438
-839
-5% -$45.3K 0.13% 128
2017
Q4
$928K Sell
17,277
-1,627
-9% -$90.2K 0.16% 121
2017
Q3
$1.16M Buy
18,904
+2,920
+18% +$177K 0.21% 103
2017
Q2
$977K Sell
15,984
-3,607
-18% -$220K 0.19% 111
2017
Q1
$1.19M Buy
19,591
+500
+3% +$30.3K 0.2% 104
2016
Q4
$1.07M Buy
19,091
+1,255
+7% +$73.4K 0.2% 107
2016
Q3
$1.06M Sell
17,836
-3,787
-18% -$221K 0.21% 99
2016
Q2
$1.19M Sell
21,623
-4,993
-19% -$266K 0.22% 94
2016
Q1
$1.34M Buy
26,616
+4,582
+21% +$224K 0.26% 85
2015
Q4
$1.11M Sell
22,034
-267
-1% -$13.5K 0.23% 85
2015
Q3
$1.05M Sell
22,301
-3,922
-15% -$208K 0.24% 84
2015
Q2
$1.42M Buy
26,223
+2,016
+8% +$113K 0.33% 67
2015
Q1
$1.33M Sell
24,207
-181
-0.7% -$10.2K 0.3% 70
2014
Q4
$1.32M Buy
24,388
+969
+4% +$54K 0.3% 71
2014
Q3
$1.32M Sell
23,419
-189
-0.8% -$10.6K 0.31% 69
2014
Q2
$1.3M Buy
23,608
+458
+2% +$25K 0.31% 70
2014
Q1
$1.25M Sell
23,150
-3,249
-12% -$168K 0.34% 63
2013
Q4
$1.26M Buy
26,399
+1,265
+5% +$57.8K 0.38% 62
2013
Q3
$1.14M Sell
25,134
-263
-1% -$12K 0.37% 57
2013
Q2
$1.13M Buy
+25,397
New +$1.13M 0.39% 60

Other funds holding MRK

Rehmann Capital Advisory Group's MRK Position: Q1 2026 in Review

Rehmann Capital Advisory Group increased its Merck (MRK) stake by 3% in Q1 2026, buying an estimated $98.9K and bringing the position to 29,158 shares worth $3.51M. The position accounts for 0.18% of the portfolio, ranked #89.

Rehmann Capital Advisory Group first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.73M in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rehmann Capital Advisory Group held 29,158 shares of Merck worth $3.51M as of Q1 2026.
  • Rehmann Capital Advisory Group bought 857 Merck shares in Q1 2026, an estimated $98.9K.
  • Merck made up 0.18% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #89 holding.
  • Rehmann Capital Advisory Group first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Rehmann Capital Advisory Group's Merck position peaked at $3.73M in Q2 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.